Financial Performance - Total net sales for the nine months ended November 30, 2024, increased to 15,383,416,representingagrowthof314,932,157 for the same period in 2023[12] - Gross profit for the nine months ended November 30, 2024, was 7,313,783,adecreaseof2.57,503,809 in the prior year[12] - Operating income for the nine months ended November 30, 2024, was 721,923,down39.51,194,764 in the same period of 2023[12] - Net income for the nine months ended November 30, 2024, was 945,700,adecreaseof26.41,284,848 for the same period in 2023[12] - For the three months ended November 30, 2024, net income was 274,178,adecreasefrom690,169 in the same period of 2023, representing a decline of approximately 60.3%[13] - Basic earnings per share for the nine months ended November 30, 2024, was 0.06,comparedto0.08 for the same period in 2023[55] Cash and Assets - Cash and cash equivalents increased significantly to 8,098,750asofNovember30,2024,from2,134,786 at the end of February 2024[10] - Total assets rose to 24,336,362asofNovember30,2024,comparedto23,132,265 as of February 29, 2024[10] - Total stockholders' equity increased to 17,400,774asofNovember30,2024,upfrom16,278,998 at the end of February 2024[10] - The company experienced a net increase in cash and cash equivalents of 5,963,964fortheninemonthsendedNovember30,2024,comparedtoadecreaseof372,670 in the prior year[20] - The balance of marketable securities decreased from 9,711,351asofFebruary29,2024,to4,582,428 as of November 30, 2024, indicating a reduction in liquid assets[31] Revenue Recognition and Sales - The Company applies ASC 606 for revenue recognition, primarily recognizing revenue from short-term contracts with customers[40][41] - The Multi-Axis Coating Systems product line accounted for 53% of total revenue for the nine months ended November 30, 2024, generating 8,158,000,comparedto7,648,000 or 51% in the same period of 2023[47] - The Integrated Coating Systems product line generated 2,850,000inrevenuefortheninemonthsendedNovember30,2024,representing1915,383,000, an increase of 3% compared to 14,932,000forthesameperiodin2023[47]−Thecompanyrecognizedapproximately3,320,000 of cash deposits as revenue during the nine months ended November 30, 2024[46] Inventory and Costs - Research and product development costs for the nine months ended November 30, 2024, were 2,054,846,adecreaseof7.52,221,712 in the prior year[12] - Net inventories as of November 30, 2024, totaled 4,737,510,downfrom5,221,980 at February 29, 2024[48] - The allowance for slow-moving inventory was recorded at 349,300asofNovember30,2024,comparedto380,400 at February 29, 2024[48] - Inventory reserve adjustments were 32,524fortheninemonthsendedNovember30,2024,downfrom41,475 in the previous year, indicating improved inventory management[20] Stock Options and Compensation - As of November 30, 2024, the Company had 212,202 stock options outstanding under the 2013 Stock Incentive Plan, with 193,139 options vested[49] - The company recognized approximately 176,000instock−basedcompensationexpensefortheninemonthsendedNovember30,2024,comparedto147,000 in 2023, reflecting an increase of approximately 19.9%[53] - The aggregate intrinsic value of the company's vested and exercisable options at November 30, 2024, was approximately 126,000[54]−Thecompanygrantedoptionstoacquire134,657sharestoemployeesduringtheninemonthsendedNovember30,2024,withaweightedaveragegrantdatefairvalueof2.54 per share[52] Foreign Sales - Sales to foreign customers accounted for approximately 5,974,000,or395,974,000, accounting for approximately 39% of total revenues[59]